The infectious disease diagnostic market (IDD market) is predicted to be worth USD 18,156 million by 2019. It is expected to grow at 8% CAGR during the forecast phase. The market is expected to grow substantially due to escalating medical advancements, rising demand for fast diagnostic systems and increased governmental spendings.
For Market Research Report on “Infectious Disease Diagnostic Market” Visit – http://www.grandviewresearch.com/industry-analysis/infectious-disease-diagnostic-market
The pivotal factors, driving the infectious disease diagnostic market are the high incidences of infectious diseases and shifting towards decentralized point of care from centralized laboratories. However, the major restraints for the market include increasing costs of healthcare and complexities in regulatory framework.
The infectious disease diagnostic market can be segmented into products, applications, techniques, consumers and geographies. The products market can be segmented into consumables, services & software and instruments & analyzers.
The infectious disease diagnostic market for applications can be fragmented into AIDS, hepatitis B & C, chlamydia trachomatics (CT) & neisseria gonorrhoeae (NG), human papillomavirus (HPV), tuberculosis and methicillin-resistant staphylococcus aureus (MRSA) hospital acquired infection.
The infectious disease diagnostic market can be fragmented on the basis of techniques into molecular diagnostics and traditional diagnostics. Molecular diagnostics can be sub-divided into hybridization, microarrays, PCR (polymerase chain reaction), INAAT (isothermal nucleic acid amplification test) and DNA sequencing. Traditional diagnostics include microscopy, immunodiagnostics and biochemical characterization.
The consumers market can be divided into reference laboratories, hospital laboratories, academics and physician laboratories. Geographically, the infectious disease diagnostic market is divided into North America, Europe, Asia Pacific and rest of the world (ROW). North America and Europe dominated the IDD market.
Asia Pacific and ROW are expected to propel further growth of the infectious disease diagnostic market. This is due high investments in healthcare sectors and rising infectious diseases in these regions.
Information Source: Grand View Research